Items where Author is "Riley, CL"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 3.

Journal article

RILEY, C.L., MATHIEU, M.G., CLARK, R.E., MCARDLE, S.E. and REES, R.C., 2009. Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable? Cancer Immunology Immunotherapy, 58 (9), pp. 1489-1499.

MATHIEU, M.G., KNIGHTS, A.J., PAWELEC, G., RILEY, C.L., WERNET, D., LEMONNIER, F.A., STRATEN, P.T., MUELLER, L., REES, R.C. and MCARDLE, S.E., 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004


RILEY, C.L., 2008. Investigation of BCR/ABL class I/II epitopes to potentiate anti-tumour responses in vivo and in vitro for the potential immunotherapy of CML. PhD, Nottingham Trent University.

This list was generated on Mon Jan 30 11:00:01 2023 UTC.